We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HVT:NYSEHaverty Furniture Companies, Inc. Analysis

Data as of 2026-04-09 - not real-time

$22.21

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Haverty Furniture is trading at $22.21, slightly above its DCF‑derived fair value of $21.65, yet still offering a ~35% upside to the analyst consensus target of $30. Technical signals are mixed: the 20‑day SMA (21.30) sits just below price, the 50‑day SMA (23.60) is above, RSI is neutral at 52, and the MACD histogram is positive, suggesting modest bullish momentum, but volume is on a decreasing trend. Recent earnings beat expectations, with Q4 EPS of $0.50 surpassing the Zacks consensus of $0.48 and comparable store sales up 8.2%, reinforcing short‑term confidence.
Fundamentally, the company posted 9.5% revenue growth YoY, maintains a solid gross margin of 60.7% and an operating margin of 5%, but net profit margin remains thin at 2.6% and ROE is only 6.4%. The dividend yield is attractive at 5.85%, however the payout ratio exceeds 100% (108%), raising concerns about sustainability. Debt‑to‑equity sits at 70%, and beta around 1.05–1.29 signals slightly higher market sensitivity, while 30‑day volatility exceeds 30%, indicating a relatively risky equity within the consumer‑cyclical sector.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Neutral technical positioning near support and resistance
  • Recent earnings beat and positive comparable sales
  • Decreasing volume and high dividend payout ratio

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Substantial upside to analyst target price
  • Strong revenue growth and healthy gross margins
  • Low forward P/E (~7.4) indicating value appeal

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Dividend sustainability concerns due to >100% payout
  • Moderate debt level and cyclicality of home‑furnishings demand
  • Brand longevity and consistent comparable‑store sales growth

Key Metrics & Analysis

Financial Health

Revenue Growth9.50%
Profit Margin2.60%
P/E Ratio18.7
ROE6.41%
ROA2.08%
Debt/Equity70.28
P/B Ratio1.2
Op. Cash Flow$52.6M
Free Cash Flow$21.9M

Technical Analysis

TrendNeutral
RSI52.5
Support$20.27
Resistance$22.60
MA 20$21.30
MA 50$23.60
MA 200$22.88
MACDBullish
VolumeDecreasing
Fear & Greed Index83.34

Valuation

Fair Value$21.65
Target Price$30.00
Upside/Downside35.07%
GradeFair
TypeBlend
Dividend Yield5.85%

Risk Assessment

Beta1.05
Volatility30.74%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.